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KEY POINTS SUMMARY 
 The vascular endothelial growth factor (VEGF) response to acute submaximal exercise 
and training effects in patients with heart failure with reduced ejection fraction (HFrEF) 
were investigated.  
 Six patients and six healthy matched-controls performed knee-extensor exercise (KE) at 
50% of maximum work-rate before and after (only patients) KE training. Muscle biopsies 
were taken to assess skeletal muscle structure and the angiogenic response.  
 Pre-training, during this submaximal KE exercise, HFrEF exhibited higher leg vascular 
resistance and greater norepinephrine spillover. Skeletal muscle structure and VEGF 
response were mostly not different between groups. Post-training, resistance was no 
longer elevated and norepinephrine spillover was curtailed in the patients. Although, in the 
trained state, VEGF did not respond to acute exercise, capillarity was augmented. Muscle 
fiber cross sectional area and %area of type I fibers increased and mitochondrial volume 
density exceeded that of controls.  
 Structural/functional plasticity and appropriate angiogenic signaling were observed in 
skeletal muscle of patients with HFrEF.  
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ABSTRACT 
Objectives This study examined the response to acute submaximal exercise and the 
effect of training in patients with heart failure with reduced ejection fraction (HFrEF). 
Background The acute angiogenic response to submaximal exercise in HFrEF after small 
muscle mass training is debated. Methods The direct Fick method, with vascular pressures, 
was performed across the leg during knee-extensor exercise (KE) at 50% of maximum work-
rate (WRmax) in patients (n=6) and controls (n=6) and then post-KE training in patients. Muscle 
biopsies facilitated the assessment of skeletal muscle structure and vascular endothelial growth 
factor (VEGF) mRNA levels. Results Pre-training, HFrEF exhibited significantly higher leg 
vascular resistance (LVR) (≈15%) and significantly greater norepinephrine (Ne) spillover 
(≈385%). Apart from mitochondrial volume density, which was significantly lower (≈22%) in 
HFrEF, initial skeletal muscle structure, including capillarity, were not different between groups. 
Resting VEGF mRNA levels, and the increase with exercise, was not different between patients 
and controls. Post-training LVR was no longer elevated and Ne spillover was curtailed. Skeletal 
muscle capillarity increased with training, as assessed by capillary-to-fiber ratio (≈13%) and 
number of capillaries around a fiber (NCAF)(≈19%). VEGF mRNA was now not significantly 
increased by acute exercise. Muscle fiber cross sectional area and % area of type I fibers both 
increased significantly with training (≈18% and ≈21%, respectively), while the %area of type II 
fibers fell significantly (≈11%), and mitochondrial volume density now exceeded that of controls. 
Conclusions These data reveal structural and functional plasticity and appropriate angiogenic 
signaling in skeletal muscle of HFrEF patients. 
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LIST OF ABBREVIATIONS 
 
HFrEF, heart failure with reduced ejection fraction 
KE, knee-extensor exercise 
LVR, leg vascular resistances 
MAP, mean arterial pressure 
MVP, mean venous blood pressure 
Ne, norepinephrine 
NYHA, New York Heart Association 
QO2, O2 delivery 
SNA, sympathetic nervous system activity 
VEGF, vascular endothelial growth factor 
WR, work rate 
VO2, oxygen consumption 
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INTRODUCTION 
Although heart failure with reduced ejection fraction (HFrEF) is fundamentally a disease 
that impacts central hemodynamics, a variety of skeletal muscle alterations, including muscle 
atrophy, a shift in fiber type, impaired oxidative capacity, reduced mitochondrial enzymes, and 
decreased mitochondrial volume density, are typically associated with this pathology (Mancini 
et al., 1992; Harrington et al., 1997; Esposito et al., 2010b; Esposito et al., 2015; Kaur et al., 
2017; Poole et al., 2017). While, in terms of the peripheral vasculature, HFrEF has also been 
linked to autonomic and cardiovascular dysregulation that leads to greater sympathetic 
vasoconstrictor tone (Magnusson et al., 1997; Kaur et al., 2017), decreased capillary-to-fiber 
ratio, reduced capillary density and smaller capillary diameter (Duscha et al., 1999; Esposito et 
al., 2010b; Piepoli et al., 2010a; Piepoli et al., 2010b; Poole et al., 2012). These findings imply 
that in addition to the inability of the heart to appropriately raise pumping capacity during 
exercise, both skeletal muscle and the peripheral vasculature also contribute to the exercise 
intolerance associated with HFrEF, a hallmark of this pathology. 
To restore exercise tolerance, traditional cardiac rehabilitation has employed whole 
body (cycle) exercise which recruits a large muscle mass and therefore taxes the central 
circulation. Although this approach has consistently yielded significant improvements in 
exercise capacity in patients with HFrEF (Hambrecht et al., 1998; Piepoli et al., 2004; Hollriegel 
et al., 2016), because whole body exercise induces a complex interaction between central and 
peripheral hemodynamics, such observations leave doubt as to the role of central and 
peripheral adaptations in response to exercise training. In an attempt to address this 
uncertainty, a growing number of studies have employed small muscle mass training, unlikely 
to stimulate central hemodynamic adaptations (Magnusson et al., 1996; Tyni-Lenne et al., 
2001). Although this innovative approach has revealed that isolated muscle training can, 
indeed, improve whole body exercise capacity in patients with HFrEF (Magnusson et al., 1996; 
Tyni-Lenne et al., 2001; Barrett-O'Keefe et al., 2014; Poole et al., 2017), the sometimes indirect 
physiological assessments used in these studies has yet to yield a clear understanding of the 
skeletal muscle structural and functional response to such exercise training in this population. 
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 Angiogenesis in skeletal muscle is an essential adaptive response to repeated exercise 
(i.e. training) resulting in an increase in skeletal muscle vascularity that, in turn, enhances O2 
transport (Esposito et al., 2010a). As vascular endothelial growth factor (VEGF) has a high 
specificity for vascular endothelial cells (Leung et al., 1989), these findings are in line with 
VEGF being a key angiogenic factor involved in structural and functional adaptations in skeletal 
muscle associated with exercise (Brodal et al., 1977; Zumstein et al., 1983; Hang et al., 1995; 
Olfert et al., 2009; Huey et al., 2016). Indeed, previously, both in healthy humans and patients 
with HFrEF, a significant increase in skeletal muscle VEGF mRNA abundance has been 
documented in response to an acute small muscle mass exercise stimulus (Gustafsson et al., 
1999; Richardson et al., 1999; Esposito et al., 2010a). Furthermore, in healthy humans we have 
documented that the previously large VEGF mRNA response to acute exercise is significantly 
attenuated as a consequence of exercise training, adding credence to the concept that VEGF is 
important in the initial phase of exercise-induced adaptation, but when significant angiogenesis 
has occurred the need and importance of this mechanism becomes greatly reduced. However, 
whether this holds true in patients with HFrEF, which is associated with a variety of 
maladaptations in the periphery, has yet to be determined.  
 Consequently, this study sought to examine skeletal muscle structure and function and 
the VEGF response to acute submaximal exercise in patients with HFrEF pre and post exercise 
training.  With the expectation that a negative feedback mechanism should exist to reduce the 
level of VEGF gene expression as exercise adaptation occurs, the purpose of this study was to 
a) document the adaptations associated with exercise training in the skeletal muscle bed of 
patients with HFrEF and b) test the hypothesis that in the face of such exercise training-induced 
adaptations, the VEGF mRNA increase in patients with HFrEF, in response to acute exercise, 
would be significantly attenuated.  
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METHODS 
Ethical Approval: After full explanation of the study design and experimental procedures, 
six male patients with HFrEF and six healthy control subjects gave written informed consent 
to participate in this study, which was approved by the University of California, San Diego 
Human Subjects Protection Program (#990152). They were all free to withdraw at any time 
without jeopardy. The study conformed to the standards set by the 1975 Declaration of 
Helsinki, except for registration in a database. 
 
Subjects: All patients with HFrEF were clinically stable with symptoms compatible with New 
York Heart Association (NYHA) functional class II-III. Mean left ventricular ejection fraction in 
the HFrEF patients was 25 ± 3%. Patient medications were not altered because of the study, 
with the exception of beta-blockers that were withheld for 48 hours prior to each 
experimental day. Particular care was taken to match patients with HFrEF and controls in 
terms of age, sex, and, especially, physical activity by questionnaire and interview (table 1). 
Several components of this study have been previously published with a focus on maximal 
exercise and the impact of exercise training in HFrEF (Esposito et al., 2011) and the VEGF 
response to acute submaximal exercise in HFrEF (Esposito et al., 2010a). Although some 
overlap is acknowledged, the current work is novel in that it combines both the acute and 
chronic responses to submaximal exercise in patients with HFrEF to better understand skeletal 
muscle plasticity in this population. 
 
Experimental Design.  An initial graded exercise test was performed on a cycle ergometer to 
document cycle WRmax and peak VO2 (VO2peak). To determine KE WRmax subjects performed an 
8-12 min graded KE test to exhaustion. Several days later, both patients with HFrEF and 
controls reported again to the laboratory and after a 5 min warm-up performed 30 min of KE at 
50% of WRmax. Both the resting and exercised legs were biopsied within one hour of the 
exercise stimulus. During KE studies, skeletal muscle blood flow and muscle 2OV
 were 
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measured. To achieve this, two catheters (radial artery and left femoral vein) and a 
thermocouple (left femoral vein) were placed using sterile technique to facilitate blood gas 
and blood flow measurements and O2 transport calculations, as previously reported 
(Richardson et al., 1993). These catheter and biopsy studies were then repeated in the 
HFrEF patients following 8 weeks of supervised KE training (3 times/week, varied intensity - 
with overall intensity progressively increased based upon biweekly assessments, 50 
min/session/leg), as previously described (Richardson et al., 2000; Lawrenson et al., 2003; 
Lawrenson et al., 2004). Exercise training compliance was evaluated as a % of training 
sessions attended.  Control subjects did not undergo training and, thus, were studied only 
once with the catheter and biopsy procedures.  
 
Exercise apparatus. The knee-extensor ergometer was utilized to produce the acute exercise 
stimulus, as previously described (Richardson et al., 1995). During exercise, the contraction 
rate was maintained at 60 repetitions per minute.  
 
Vascular and metabolic measurements. The continuous infusion thermodilution approach 
was used to measure blood flow during exercise, as previously described (Richardson et al., 
1993). Femoral arterial and venous blood pressures were continuously monitored at heart 
level by pressure transducers (model PX-MK099, Baxter). Mean arterial pressure (MAP) and 
mean venous blood pressure (MVP) were computed by the integration of each pressure 
curve. Leg vascular resistance (LVR) was calculated as (MAP–MVP)/muscle blood flow. 
Before each blood flow measurement, three to four ml samples of arterial and femoral 
venous blood were withdrawn from the catheters anaerobically to measure PO2, PCO2, pH, 
O2 saturation, and hemoglobin concentration ([Hb]). All measurements were made on an IL 
1306 blood gas analyzer and IL 482 CO-oximeter (Instrumentation Laboratories, Lexington, 
MA.). Arterial and venous O2 concentrations were calculated as [1.39 ml O2 x [Hb] g/100 ml 
x O2 saturation (%)] + [0.003 ml O2/100 ml of blood x PO2 (mmHg)]. Arterial-venous O2 
concentration difference was calculated from the difference in radial artery and femoral 
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venous O2 concentration measurements. Muscle VO2 was calculated as the product of blood 
flow and arterial-venous O2 difference, while O2 delivery (QO2) was calculated as the product 
of blood flow and arterial O2 concentration.  
 
Norepinephrine spillover.  Epinephrine and norepinephrine (Ne) were extracted from 
plasma using a cis-diol-specific affinity gel, acylated, derivatized enzymatically and then 
assayed by competitive ELISA using the microtiter plate format, as previously described 
(Wadley et al., 2006). The rate of Ne spillover was determined, as described previously 
(Savard et al., 1989), using the following equation: 
 Ne spillover = [(Cv-Ca) + Ca (Ee)] * LPF 
where Cv and Ca are plasma Ne concentrations in the common femoral vein and radial 
artery, respectively.  Ee is the fractional extraction of epinephrine, measured across the 
muscle bed, and LPF is the leg plasma flow, determined from leg blood flow and hematocrit.  
 
KE training. Following the initial catheter-based studies, subjects returned to the laboratory 
three times each week for eight weeks to complete supervised KE training of varying intensity 
for 100 min exercise periods (50 min/leg), as previously described (Richardson et al., 2000).  
 
Quadriceps Muscle mass. Utilizing thigh length, circumferences, and skin-fold measurements, 
thigh volume was calculated to allow an estimate of quadriceps muscle mass, as utilized 
previously (Jones & Pearson, 1969; Andersen et al., 1985) 
 
Muscle biopsy. All biopsies were taken from the vastus lateralis muscle at an approximate 
depth of 3-5 cm, 15 cm proximal to the knee and slightly distal to the ventral midline of the 
muscle using a Bergstrom needle, as described previously (Bergstrom, 1975). The muscle 
samples from each biopsy were either immediately frozen in liquid nitrogen and stored at -80°C 
for subsequent histochemical analysis or immersion-fixed in glutaraldehyde fixative and later 
processed for electron microscopy and morphometry.  
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Histochemistry. Eight µm-thick transverse sections were cut at -24°C on a cryostat (Jung-
Reichert Cryocut 1800) and stained for fiber types I and II, and capillaries (Rosenblatt et al., 
1987). 
 
Electron microscopy. The glutaraldehyde-fixed samples were processed for electron 
microscopy, as described previously (Mathieu-Costello, 1987).  
 
Morphometry. The relative cross-sectional area and number of type I and type II fibers was 
estimated by point-counting on a light microscope (250x) using an eyepiece square grid test 
A100 (Weibel, 1979). Capillary density (i.e. capillary number per fiber cross-sectional area), 
capillary-to-fiber ratio (i.e. capillary number per fiber number), number of capillaries around a 
fiber (NCAF) and fiber cross-sectional area were measured by point-counting with a light 
microscope (400x). The volume density of mitochondria per volume of muscle fiber was 
estimated by point-counting (490x).  
 
VEGF mRNA levels. The relative VEGF mRNA levels in skeletal muscle from healthy controls 
and patients with HFrEF was measured by competitive reverse transcriptase polymerase chain 
reaction (RT-PCR) analysis according to the method of Zachar (Zachar et al., 1993). The gel 
was quantified by computer densitometry (GelPro Analyzer, Media Cybernetics, Silver Springs, 
MD). VEGF mRNA signals were then expressed as the ratio of VEGF target DNA/internal 
standard in arbitrary units (AU). It should be noted that VEGF protein expression was not 
assessed as it is well accepted that VEGF undergoes pretranslational regulation (Gustafsson & 
Kraus, 2001) and also because of the differing time course of  VEGF mRNA and VEGF protein 
expression (1 vs 4 hrs, respectively (Gustafsson & Kraus, 2001), that would have required an 
additional biopsy, which was not performed for ethical reasons.  
 
Statistical analysis. Subject characteristics for patients with HFrEF and healthy controls were 
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compared using unpaired Student t-tests. Variables assessed in the rested state and following 
acute exercise were assessed by ANOVA. Differences between groups and conditions were 
then identified using a Newman-Keuls post-hoc analysis. Despite the relatively small sample 
size, a priori power calculations, based upon our previously published assessments of the 
acute VEGF mRNA response to exercise and muscle morphometry (Richardson et al., 1999; 
Richardson et al., 2000; Esposito et al., 2010a), revealed adequate power (> 0.8) in the major 
variables of interest. Statistical significance was accepted if P<0.05. All data are reported as 
mean  standard error. 
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RESULTS 
Subjects Characteristics: Prior to exercise training, the only statistically significant different 
anthropometric characteristic between the patients and controls was body mass, which was 
higher in the patients with HFrEF. Post-training, body mass was unchanged while 
quadriceps muscle mass was 15% greater (Table 1).  
 
Exercise Training Compliance: The individualized approach to the exercise training with 
supervision in the laboratory resulted in a 98% compliance to the prescribed exercise 
regimen. Due to sickness, a single patient with HFrEF did not complete the post training 
assessments and so was excluded from all analyses.  
 
Maximal bike and KE  pre- and post-KE training: Cycle exercise WRmax and pulmonary 
VO2peak were significantly lower in the patients with HFrEF compared to the controls pre 
training, however, after training, both WRmax and pulmonary VO2peak increased to equal that 
of the (untrained) controls (Table 1). Knee-extensor maximum was also attenuated in the 
patients with HFrEF, but, as a consequence of the KE training, KE WRmax increased to equal 
that of the control subjects. Therefore, the initial 50% of KE WRmax, employed as the 
standard exercise stimulus pre training was, in absolute terms, lower than that for controls, 
but after training this relative exercise intensity was equal to the controls in both absolute 
and relative terms (Table 2).  
 
Muscle metabolic and vascular response to acute submaximal exercise: As the 50% of 
WRmax exercise stimulus was, pre exercise training, in absolute terms, lower for the patients 
with HFrEF, muscle blood flow and muscle VO2 were lower than that exhibited by controls. 
Interestingly, prior to the exercise training, patients with HFrEF exhibited a ≈15% higher LVR 
than the controls which, following the exercise training, was reduced to a level that was not 
different from the controls (figure 1). Furthermore, a reciprocal change in Ne spillover was 
documented as a consequence of the exercise training (figure 1). Additional O2 transport and 
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metabolic data are presented in Table 2.  
 
Muscle capillarity and VEGF mRNA: Prior to exercise training there was no significant 
difference in capillary-to-fiber ratio or number of capillaries around a fiber between patients and 
controls (figure 2). As a consequence of training, the patients exhibited a significant increase in 
capillary-to-fiber ratio and the number of capillaries around a fiber (figure 2).  Representative 
VEGF mRNA gels for patients with HFrEF and controls are presented with the quantification of 
these signals in Figure 2. In the rested leg VEGF mRNA levels were not different in the controls 
and the patients with HFrEF both pre and post exercise training (0.33 ± 0.04, 0.39 ± 0.03, and 
0.38 ± 0.04 AU, respectively; P>0.05) (figure 2). One hour following acute knee-extensor 
exercise, both the controls and the patients with HFrEF pre exercise training exhibited a 
significant increase in VEGF mRNA levels in the vastus lateralis muscle (0.78 ± 0.07 and 0.71 ± 
0.07 AU in controls and HFrEF pre, respectively; figure 2). This increase in VEGF mRNA 
abundance, as a consequence of acute exercise, was not different in both the patients with 
HFrEF and controls. Consequently, the VEGF mRNA exercise-to-rest ratio was not different 
between controls and patients with HFrEF pre training (2.5 ± 0.5, and 1.8 ± 0.4 AU, 
respectively; figure 2). In contrast, in the trained state, the acute exercise-induced change in 
VEGF mRNA abundance in the patients with HFrEF (0.49 ± 0.04 AU) was not significantly 
different from rest (figure 2) and the VEGF mRNA exercise-to-rest ratio was attenuated 
compared to the controls and patients pre training (1.3 ± 0.4 AU; figure 2). 
 
Capillary density, fiber type, and fiber area: Prior to exercise training, muscle structural 
characteristics for both patients with HFrEF and controls were very similar, with no significant 
difference in capillary density, % area of type I and II fibers, fiber cross sectional area, between 
patients and controls (figure 3). Interestingly, capillarity, in this case assessed as capillary 
density, was unchanged by the exercise training performed by the patients with HFrEF, likely 
because of concomitant muscle fiber changes. Specifically, the % area of type I fibers was 
significantly increased, while the % area of type II fibers was reduced. Furthermore, the 
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exercise training induced an increase in fiber cross sectional area.  
 
Mitochondrial volume density and capillarity: Prior to exercise training, mitochondrial 
volume density was significantly lower (22%, P<0.05) in the patients with HFrEF compared to 
the controls (figure 4). As a result of the exercise training, the patients exhibited a significant 
increase in mitochondrial volume density. This increase in mitochondrial volume density was 
such that, post training, there was no longer a difference between patients and controls (figure 
4). Interestingly, as illustrated in the inlay in figure 4, there was a significant positive relationship 
between capillarity, assessed as NCAF, and mitochondrial volume density when these variables 
were considered pre and post exercise training in the patients with HFrEF. 
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DISCUSSION 
To better understand exercise-induced skeletal muscle structural and functional 
plasticity in patients with HFrEF, this study sought to assess the response to acute submaximal 
exercise in such patients both before and after KE training and compare them with well-
matched controls. This approach yielded several interesting findings. In terms of function, prior 
to exercise training, assessed at 50% of WRmax, the patients with HFrEF exhibited higher LVR 
and much greater Ne spillover. Skeletal muscle structure, with the exception of mitochondrial 
volume density that was significantly lower in the patients with HFrEF compared to the controls, 
including measures of capillarity and fiber type, was not different between the two groups. 
Resting and acute exercise-induced VEGF mRNA levels were not different between patients 
and controls. Post exercise training the patients no longer exhibited elevated LVR and Ne 
spillover was reduced. Skeletal muscle capillarity increased after exercise training, as assessed 
by capillary-to-fiber ratio and NCAF, and VEGF mRNA was no longer increased by the acute 
exercise stimulus. Muscle fiber cross sectional area was increased by the training and there 
was an augmented % area of type I fibers and fall in the area of the type II fibers. Finally, 
exercise training restored mitochondrial volume density, exceeding that of the controls. 
Collectively, these data provide evidence of structural and functional plasticity and appropriate 
angiogenic signaling in response to acute exercise in the skeletal muscle of patients with 
HFrEF.  
 
Muscle metabolic and vascular response to acute exercise: A unique component of this 
study was that the physiological response to the acute KE stimulus was well documented in 
terms of metabolism and hemodynamics (table 2). An initial important observation was that, pre 
training, maximal WR and leg VO2 were significantly lower in the patients with HFrEF than the 
well-matched controls. Indeed, guided by the concept that training-induced adaptations are 
predominantly stimulated by relative and not absolute WR, the pre training selection of 50 % of 
WRmax in both groups resulted in this lower metabolic and vascular challenge for the patients 
than the controls. Specifically, pre training leg muscle blood flow, QO2, and leg VO2 at 50% of 
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WRmax were 16%, 13%, and 12% lower, respectively, in the patients with HFrEF. However, post 
training, due to the improvement in maximal exercise capacity of the patients with HFrEF, there 
was no longer a difference in the absolute WR that equated to 50% of WRmax and, therefore, 
the metabolic and vascular stress imposed by the acute submaximal exercise was no longer 
lower than that of the controls and the response of the patients could now be, legitimately, 
compared to that of the controls. 
Neurohumoral activation, including increased sympathetic nervous system activity 
(SNA), is a hallmark characteristic of advanced HFrEF (Esposito et al., 2010b; Kaur et al., 
2017) and, typically, those patients with the greatest SNA have the poorest chance of 
survival (Cohn et al., 1984). So strong is this link, almost every pharmacologic intervention 
proven to increase survival in HFrEF interrupts this increase in SNA (Packer et al., 2001). 
Exercise training, on the other hand, has clear beneficial effects, but data regarding the 
effect of exercise training on SNA in HFrEF have been equivocal. For example direct SNA 
measurements with mircroneurography revealed a reduction in resting SNA in patients with 
HFrEF following exercise training (Roveda et al., 2003). In contrast, a study, more similar to 
the current work (Gordon et al., 1997), evaluated patients with HFrEF before and after 8 
weeks of two-legged KE training, and although documenting many benefits of chronic 
exercise in this population, training did not alter resting Ne levels. The current study supports 
the latter pre training findings, with evidence of elevated Ne spillover and greater LVR in the 
patients with HFrEF. Of note, the elevated LVR was reversed by KE training and 
accompanied by a fall in Ne spillover (figure 1). Thus, in contrast to our previous study 
focused upon maximal exercise (Esposito et al., 2011), the current data support a link 
between the benefits of exercise training and a reduction in SNA at a submaximal exercise 
intensity in patients with HFrEF. It is, of course, plausible that other exercise training-induced 
vascular adaptations, such as improved vascular endothelial function, contributed to the 
reduction in vascular resistance in the patients with HFrEF, but this is beyond the scope of 
the current study. 
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Skeletal muscle vasculature and VEGF: Prior to training, both the patients with HFrEF and 
the controls muscle vascular characteristics were very similar, with no significant differences in 
capillary-to-fiber ratio or NCAF or capillary density. As a consequence of training, the patients 
exhibited a significant increase in both capillary-to-fiber ratio and NCAF, but, ultimately, there was 
still no difference between groups in terms of these indices of capillarity (figure 2). In the current 
study and in our previous work (Esposito et al., 2010a), the VEGF mRNA response to acute 
exercise in the untrained patients with HFrEF was not different from the healthy controls (figure 
2). As VEGF functions as a direct angiogenic factor with a high specificity for vascular 
endothelial cells (Neufeld et al., 1999; Wahl et al., 2014) these findings are in line with the well-
accepted critical role of VEGF in the formation of new blood vessels in human skeletal muscle, 
including patients with HFrEF, in response to exercise (Gustafsson et al., 2001; Esposito et al., 
2010a).  
 Angiogenesis is an essential adaptive response in skeletal muscle to chronic exercise 
(i.e. training) resulting in an increase in the number of capillaries per muscle fiber that enhances 
O2 transport conductance between the microcirculation and mitochondria (Gustafsson et al., 
2001; Esposito et al., 2010a). The present data extend the link between VEGF and capillary 
proliferation to include the observation that following significant adaptations to exercise training, 
including angiogenesis, the previously large VEGF mRNA response to acute exercise in 
patients with HFrEF is significantly attenuated (figures 2). This finding adds credence to the 
concept that VEGF is important in the initial phase of exercise adaptation in patients with 
HFrEF, but when significant angiogenesis has occurred, due to training, the need and 
importance of this mechanism becomes significantly reduced. It should be noted that although 
VEGF protein levels were not assessed in the current study, previous findings have 
documented proportional changes in VEGF mRNA and protein expression in this population 
(Gustafsson et al., 2001). Collectively, these data document the exciting and clinically relevant 
observation that the capacity of acute exercise to initiate the process of new capillary growth 
and the maintenance of existing vessels (i.e. increasing VEGF mRNA levels) is still intact in the 
skeletal muscle of patients with HFrEF. 
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Skeletal muscle mass and fiber type plasticity: Although HFrEF is often associated with 
muscle atrophy, this was not the case in the current patients in comparison to controls, 
despite the patients being predominantly defined as NYHA Class III. Indeed, likely due to the 
greater body mass in the patients, muscle mass actually tended to be greater in the patient 
group prior to KE training (Table 1). Following the 8 weeks of KE training, this initial 
tendency was translated into a significantly greater muscle mass in the patients compared to 
the, untrained, controls (Table 1). HFrEF is often associated with not only muscle atrophy 
and skeletal muscle dysfunction, but also with a shift in fiber types from “slow”, aerobic, 
fatigue-resistant (myosin heavy chain I, MHC1) to the “fast” more fatigable fibers (MHC2a 
and MHC2x) (Mancini et al., 1992; Narumi et al., 2015). Although not statistically different, in 
this regard, from controls, the current patients with HFrEF were no exception to this theme 
demonstrating a strong trend to a reduced % area of type I and increased % area of type II 
fibers in comparison to the controls (figure 4). Of note, considerable effort was made to find 
control subjects who exhibited not only similar age and anthropometric characteristics, but 
also a similar level of daily physical activity as the patients with HFrEF (i.e. relatively 
inactive) as this, in and of itself, may influence muscle structure. In agreement with this 
concept, KE training significantly increased the % of type I and decreased the % of type II 
fibers, with the patients, post training, now exhibiting fiber type proportions that were now not 
different to the controls (figure 4). 
 
Skeletal muscle mitochondrial volume density: Interestingly, the only morphometric 
difference pre training between patients with HFrEF and controls was at the subcellular level 
with mitochondrial volume density in HFrEF patients being 22% lower than in controls (figure 4). 
Of further note, and germane to the current focus on the vasculature, when training-induced 
mitochondrial biogenesis restored mitochondrial volume density to levels in the patients with 
HFrEF to that of the controls, pre and post training mitochondrial volume densities were 
significantly correlated with pre and post NCAF values (figure 4, inlay). This finding reinforces the 
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likely teleological link between the skeletal muscle metabolic machinery and the vasculature, 
and implies that this important relationship is still intact in patients with HFrEF (Poole & 
Mathieu-Costello, 1996).  
 
Perspective: The exercise-induced skeletal muscle structural and functional improvements 
in patients with HFrEF, documented herein, provide evidence of significant peripheral 
vascular and metabolic plasticity in this population that can be developed with small muscle 
mass training and then harnessed to benefit whole body exercise capacity. Additionally, 
these findings highlight the intact nature of skeletal muscle specific processes such as 
angiogenesis and mitochondrial biogenesis in patients with HFrEF allowing the contributions 
of these peripheral factors to be targeted, perhaps guiding clinical interventions in the future. 
 
Translational Perspectives 
This study has documented skeletal muscle structural and functional plasticity and appropriate 
angiogenic signaling in response to acute submaximal exercise in patients with HFrEF. In 
practical terms, small muscle mass exercise training appears to hold significant promise in 
terms of promoting peripheral adaptation in the apparently still responsive skeletal muscle of 
patients with HFrEF. These observations may contribute to a more focused, evidence-based 
non-pharmacological component of HFrEF treatment by physicians. The same strategical 
approach could be proposed also to other pathological scenarios, such as chronic obstructive 
pulmonary disease, where the central component of oxygen delivery is compromised but their 
disuse-induced peripheral maladaptation at the skeletal muscle level could be reversed by 
small muscle mass physical training. 
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Table 1. Characteristics of healthy controls and patients with heart failure with reduced 
ejection fraction (HFrEF) pre and post 8 weeks of knee-extensor exercise training. 
 Controls HFrEF pre HFrEF post 
Age (yrs) 51 ± 8 54 ± 14 54 ± 14 
Height (cm) 179 ± 7 182 ± 6 182 ± 6 
Body Mass (kg) 90 ± 11 100 ± 4 101 ± 4 
Quadriceps muscle mass (kg) 2.4 ± 0.4 2.6 ± 0.1 3.0 ± 0.1*# 
NYHA class - II-III II-III 
KE Maximum Cardiac Output (l/min) 10.9 ± 1.2 9.0 ± 1.2 9.4 ± 1.1 
Peak Pulm. Cycle VO2 (l/min) 2.14 ± 0.10 1.63 ± 0.09
# 2.02 ± 0.15* 
Peak Pulm. Cycle VO2 (ml/kg/min) 24.1 ± 1.1 15.3 ± 18.6
# 18.6 ± 1.6*# 
Maximum cycle work rate (W) 148 ± 8 115 ± 13# 141 ± 16* 
Cycle Maximum Cardiac Output (l/min) 16.8 ± 0.8 13.6 ± 1.2# 14.3 ± 1.4# 
Medications (fraction of users)    
Digoxin - 5/5 5/5 
Diuretics - 5/5 5/5 
Long-acting nitrates - 3/5 3/5 
Statins - 4/5 4/5 
Aspirin - 3/5 3/5 
ß-Blockers - 4/5 4/5 
Warfarin - 2/5 4/5 
ACE inhibitors - 2/5 4/5 
Ca2+ channel blockers - 2/5 4/5 
 
NYHA, New York Heart Association; KE, knee-extensor; Pulm., pulmonary; VO2 leg, oxygen 
uptake; Ca2+, calcium. Data are expressed as mean ± SE. *P<0.05 post vs pre; #P<0.05 
HFrEF vs controls. 
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Table 2. Vascular and metabolic response to knee-extensor exercise at 50% of maximum 
work rate (WRmax) in healthy controls and in patients with heart failure with reduced ejection 
fraction (HFrEF) pre and post 8 weeks of knee-extensor exercise training. 
 
 Controls HFrEF pre HFrEF post 
50% WRmax (W) 20 ± 3 15 ± 2
# 21 ± 3 
HR (b/min) 94  3 92  6 90  3 
VO2 leg (ml/min) 313  28 275 ± 23.5
# 324 ± 17* 
 
 Q leg (ml/min) 2450  223 2048 ± 159
# 2529 ± 238* 
QO2 leg (ml/min) 460  41 401 ± 28
# 476 ± 48* 
Hb (g/dl) 13.9  0.3 12.7 ± 0.6 13.1 ± 0.5 
SaO2 (%) 96   1 97.1 ± 0.6 97.7 ± 0.4 
CaO2 (ml/100ml) 18.8  0.3 17.3 ± 0.9 18.1 ± 0.8 
CvO2 (ml/100ml) 5.9  0.5 4.4 ± 0.6 5.2 ± 0.9 
PaO2 (mmHg) 99.9  3 95.3 ± 6.2 93.6 ± 3.5 
PvO2(mmHg) 23.0  1.1 19.6 ± 0.9 20.3 ± 1.2 
LVR (mmHg/L/min) 41 ± 6 47  ± 7# 39 ± 6*# 
MAP (mmHg) 121  11 110  6 112  7 
MAP-MVP (mmHg) 100 ± 12 95 ± 7 95 ± 6 
Ne Spillover (nM/min) 0.68 ± 0.2 3.30 ± 0.3# 1.43 ± 0.5*# 
 
 
WRmax, maximum work rate; VO2 leg, leg oxygen uptake; HR, Heart rate; Q leg, leg blood 
flow; QO2 leg, leg oxygen delivery; SaO2, arterial O2 saturation;  CaO2, arterial O2 
concentration; CvO2, venous O2 concentration; PaO2, arterial O2 partial pressure; PvO2, 
venous O2 partial pressure; LVR, leg vascular resistance; MAP, mean arterial pressure; 
MVP, mean venous pressure; Ne, norepinephrine. Data are expressed as mean  SE; 
*P<0.05 (post vs pre); #P<0.05 (HFrEF vs controls). 
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FIGURE LEGENDS 
 
Figure 1. Leg vascular resistance and norepinephrine spillover across the leg of 
untrained healthy controls and patients with chronic heart failure with reduced ejection 
fraction (HFrEF) pre and post knee-extensor exercise (KE) training during KE at 50% of 
maximal KE capacity. Data illustrated as mean ± SE. *P<0.05 post vs pre; #P<0.05 HFrEF vs 
controls. 
Figure 2. Skeletal muscle capillary-to-fiber ratio, number of capillaries around a fiber, 
and the % increase in VEGF mRNA expression following knee-extensor exercise (KE) at 
50% of maximal KE work rate in untrained healthy controls and patients with chronic 
heart failure with reduced ejection fraction (HFrEF) pre and post KE training. Data 
illustrated as mean ± SE. *P<0.05 post vs pre; #P<0.05 HFrEF vs controls. 
Figure 3. Skeletal muscle capillary density, fiber cross section area, % area type I fibers, 
and % area type II fibers in untrained healthy controls and patients with chronic heart 
failure with reduced ejection fraction (HFrEF) pre and post knee-extensor exercise (KE) 
training. Data illustrated as mean ± SE. *P<0.05 post vs pre; #P<0.05 HFrEF vs controls. 
Figure 4. Skeletal muscle mitochondrial volume density in untrained healthy controls 
and patients with chronic heart failure with reduced ejection fraction (HFrEF) pre and 
post knee-extensor exercise (KE) training. Inlay illustrates the relationship between 
capillarity and mitochondrial volume density content pre and post KE training in the 
patients with HFrEF.  Data illustrated as mean ± SE. *P<0.05 post vs pre; #P<0.05 HFrEF vs 
controls. 
  
 




